Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See
full details
.
I Agree
×
Join today and have your say! It’s FREE!
Join Now
Sign In
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.
Join Today
or
Sign in with existing account
Privacy Policy
|
Disclaimer
Sign In
Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Remember me
Forgot Password?
Sign In
or
Sign Up
Privacy Policy
|
Disclaimer
Please Try Again
{{ error }}
Send my password
Submit
Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.
Become a member today, It's free!
We will not release or resell your information to third parties without your permission.
Linking with Facebook:
Stockhouse membership requires an email address which must be shared by Facebook.
By default, joining or signing in using your Facebook account will work and the email address will be shared by Facebook automatically.
If you change your Facebook permissions to restrict Stockhouse from receiving your email while joining or signing in to Stockhouse then it will fail.
Please do not modify the permission settings during sign-in.
Sign in with Facebook
Return to Signup Options
Home
Community
Bullboards
Blogs
Groups
Messages
Markets
Stocks
TSX
TSXV
CSE
Cboe Canada
NASDAQ
NYSE
NYSE American
Cryptocurrency
Currencies
Market Movers
Bonds
News
Featured News
Trending News
Canadian Press Releases
US Press Releases
Video
Editorial
Thematic Insights
Independent Reports
Interviews
Buzz on the Bullboards
Portfolio
Watchlist
Portfolio
Showcase Companies
DealRoom
Quote
|
Bullboard
|
News
|
Opinion
|
Profile
|
Peers
|
Filings
|
Financials
|
Options
|
Price History
|
Ratios
|
Ownership
|
Insiders
|
Valuation
Bullboard - Stock Discussion Forum
Filament Health Corp
N.FH
Alternate Symbol(s):
FLHLF
Healthcare
Psychedelics
Filament Health Corp. is a Canada-based clinical-stage natural psychedelic drug development company. The Company’s platform of intellectual property enables the discovery, development, and delivery of natural psychedelic medicines. The Company’s first three botanical drug candidates are standardized, purified extracts of Psilocybe cubensis fruiting bodies include: PEX010 Psilocybin - oral...
delivery (1mg and 25mg), PEX020 Psilocin - oral delivery (dose withheld), and PEX030 Psilocin - sublingual delivery (dose withheld). The Company's preclinical stage drug candidates include AEX010 Ayahuasca - oral delivery (dose withheld), and AEX020 Monoamine Oxidase Inhibitor - oral delivery (dose withheld). The Company’s internal drug discovery and development program is carried out by its wholly owned subsidiary, Psilo Scientific Ltd., and is focused on developing standardized pharmaceutical-grade drug candidates from botanical psychedelic biomass.
see more
Join the community and start posting on the bullboards today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Create a portfolio watchlist today. It's free.
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Add To Watchlist
Bullboard (NEO:FH)
New Post
View:
Posts & Comments
Threaded Posts
Prev
1
2
Next
(0)
•••
letdgirard
X
Post by
letdgirard
on Apr 15, 2025 8:47am
Why!
Hier il y a eu beaucoup d'activit sur le titre... beaucoup de volume. Quelqu'un sait pourquoi?
(68)
•••
dothemathpeople
X
Post by
dothemathpeople
on Feb 25, 2025 10:27am
Is this company about to delist?
Seems like nobody is home. Too bad they have paid zero attention, to their market. Maybe when they need more money, they will firm up the stock, and place some higher. But I gotta
...more
(68)
•••
dothemathpeople
X
Post by
dothemathpeople
on Dec 16, 2024 12:17pm
6 kilos?
Seems like a little.
(68)
•••
dothemathpeople
X
Comment by
dothemathpeople
on Oct 16, 2024 8:31am
RE:Nothing doing
No nothing company. Well done.
(68)
•••
dothemathpeople
X
Post by
dothemathpeople
on Sep 04, 2024 8:20am
Nothing doing
In here. What is this company even doing anymore?
(68)
•••
dothemathpeople
X
Post by
dothemathpeople
on May 07, 2024 9:06am
Too many geniuses,
Not enough smart people. This company should be doing much better than they are. Talk about being lost in a space. They need a market savy, experienced equity guy/gal in house. It
...more
(0)
•••
fossil8
X
Post by
fossil8
on Jan 02, 2024 6:48pm
Deal
I am one happy camper that this deal did not go through. It was bad from the get go. What has not been reported is what the cost was to walk away and WHY was it terminated. Filament is bleeding
...more
(1710)
•••
lscfa
X
Post by
lscfa
on Sep 27, 2023 11:19am
Jupiter redemptions
Jupiter had $160 million cash at March 31, 2023 and $15 million at June 30, 2023
(1710)
•••
lscfa
X
Comment by
lscfa
on Aug 15, 2023 11:23am
RE:1-for-10 rollback
Jupiter has $217 mil Cdn cash & securities but assuming 90% redemptions and $13.3 mil transaction costs so only $7 mil cdn cash after RTO and total of 29.3 mil shs o/s
(1710)
•••
lscfa
X
Post by
lscfa
on Aug 15, 2023 11:01am
1-for-10 rollback
Filament shareholders only get 20,600,000 shares in merged co. This is 1/10 of FH shares o/s. https://www.sec.gov/Archives/edgar/data/1988363/000121390023067070/ff42023
...more
(0)
•••
fossil8
X
Post by
fossil8
on Aug 08, 2023 7:27pm
Patience Required
This stock is going to rock especially with the new alliance. Doors will open now and funds will be available. Got a dream team running it. We will all have to be patient but it is a
...more
(2269)
•••
Betteryear2
X
Post by
Betteryear2
on Jun 30, 2023 8:09am
FILAMENT HEALTH ENTERS EXCLUSIVE LICENSING AGREEMENT
NeoLumina's license for Filament's botanical psilocybin drug candidate provides exclusive global right to clinical and commercial development for eating disorders VANCOUVER, BC, June 30
...more
(86)
•••
Firepoker
X
Post by
Firepoker
on Apr 26, 2023 8:09am
2023 Spring Event and Media Appearances
https://www.filament.health/news/filament-health-announces-spring-2023-event-and-media-appearances
(86)
•••
Firepoker
X
Post by
Firepoker
on Apr 26, 2023 8:04am
Filament TV interview on CTV today...excellent exposure for
CTV your morning at 8:10am eastern 5:10 pacific MEDIA -On Wednesday, April 26, at 8:10 a.m. ET, Mr. Lightburn will appear on CTV’s Your Morning to discuss the Company’s recent development of GMP MDMA
...more
(86)
•••
Firepoker
X
Post by
Firepoker
on Apr 22, 2023 6:55am
Great Partnership
https://mugglehead.com/pharmala-biotech-and-filament-health-partner-to-release-mdma-capsules/
Prev
1
2
Next
Thank You
Your Report has been submitted.
Report Abusive Content
×
Close
Sign up to get access
You are already a member! Please enter your password to sign in.
Remember me
Forgot password?
Back
Submit
By providing my email, I consent to receiving messages from Stockhouse.
Market Update
{{currentVideo.title}}
{{currentVideo.relativeTime}}
{{previousButtonTitle}}
{{nextButtonTitle}}
A daily snapshot of everything
from market open to close.
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}
{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >
Featured News Links
Healthcare and Clinical Stage Drug Development Company Acquires NoBrainer Imaging Centers